PRELUDE CAPITAL MANAGEMENT, LLC - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 78 filers reported holding CHEMBIO DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q2 2020$170,000
+16900.0%
52,252
+19996.9%
0.01%
Q1 2019$1,000
-88.9%
260
-67.5%
0.00%
-100.0%
Q2 2018$9,0008000.00%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,150,925$7,826,0002.91%
New Jersey Better Educational Savings Trust 158,000$1,074,0000.69%
ARS Investment Partners, LLC 620,936$4,222,0000.65%
PERKINS CAPITAL MANAGEMENT INC 68,050$463,0000.51%
First Light Asset Management, LLC 76,302$519,0000.23%
Kovack Advisors, Inc. 33,509$228,0000.11%
WHITE PINE CAPITAL LLC 32,625$222,0000.09%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 97,823$665,0000.06%
TAURUS ASSET MANAGEMENT, LLC 17,000$116,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 107,500$731,0000.01%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders